CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Axim Biotechnologies, Inc.  (AXIM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

AXIM's Revenue Year on Year Growth by Quarter and Year

Axim Biotechnologies,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
AXIM Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 0.01 0.04 - 0.00
III Quarter September 0.01 0.01 0.01 0.00
II Quarter June 0.01 - -0.05 0.00
I Quarter March 0.01 -0.06 0.00 0.00
FY   0.04 -0.01 -0.04 -

Financial Statements
Axim Biotechnologies,'s forth quarter 2016 Revenue $ 0.01 millions AXIM's Income Statement
Axim Biotechnologies,'s forth quarter 2015 Revenue $ 0.04 millions Quarterly AXIM's Income Statement
AXIM's Growth by Division See AXIM's Growth by Segment

AXIM Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December -69.47 % - - -
III Quarter September 0 % 0 % - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -



AXIM Revenue Growth Comment
Axim Biotechnologies, Inc. reported drop in Revenue in the forth quarter by -69.47% to $ 0.01 millions, from the same quarter in 2015.
The fall in the forth quarter Axim Biotechnologies, Inc.'s Revenue compares unfavorably to the Company's average Revenue decrease of -4.24%.

Looking into forth quarter results within Biotechnology & Drugs industry 72 other companies have achieved higher Revenue growth. While Axim Biotechnologies, Inc.' s Revenue drop of -69.47% ranks overall at the positon no. 3524 in the forth quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #73
Healthcare Sector #409
S&P 500 #3524
Revenue Y/Y Growth Statistics
High Average Low
61.49 % -4.24 % -67.02 %
(Jun 30 2015)   (Dec 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AXIM's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AXIM's Competitors
Revenue Growth for Axim Biotechnologies,'s Suppliers
Revenue Growth for AXIM's Customers

You may also want to know
AXIM's Annual Growth Rates AXIM's Profitability Ratios AXIM's Asset Turnover Ratio AXIM's Dividend Growth
AXIM's Roe AXIM's Valuation Ratios AXIM's Financial Strength Ratios AXIM's Dividend Payout Ratio
AXIM's Roa AXIM's Inventory Turnover Ratio AXIM's Growth Rates AXIM's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Opexa Therapeutics, Inc. -0.00 %$ -0.000 millions
Phibro Animal Health Corp -0.09 %$ -0.091 millions
Misonix Inc -0.15 %$ -0.149 millions
Abaxis Inc -0.20 %$ -0.197 millions
Opko Health, Inc. -0.25 %$ -0.254 millions
Magellan Health Inc -0.42 %$ -0.422 millions
Tandem Diabetes Care Inc -0.71 %$ -0.714 millions
Merck & Co., Inc. -0.98 %$ -0.979 millions
Bruker Corp -1.65 %$ -1.652 millions
Alpha Pro Tech Ltd -1.87 %$ -1.874 millions
Becton Dickinson & Co -2.14 %$ -2.143 millions
Brookdale Senior Living Inc. -2.17 %$ -2.172 millions
Sangamo Therapeutics, Inc -2.18 %$ -2.182 millions
Aoxing Pharmaceutical Company, Inc. -2.28 %$ -2.278 millions
Haemonetics Corp -2.38 %$ -2.375 millions
Encision Inc -2.74 %$ -2.739 millions
Pfizer Inc -2.99 %$ -2.990 millions
Tenet Healthcare Corp -3.68 %$ -3.676 millions
Chembio Diagnostics, Inc. -3.75 %$ -3.754 millions
Fate Therapeutics Inc -4.55 %$ -4.554 millions
Twinlab Consolidated Holdings, Inc. -4.75 %$ -4.749 millions
Enteromedics Inc -4.77 %$ -4.765 millions
Owens & Minor Inc -4.81 %$ -4.805 millions
Nektar Therapeutics -4.88 %$ -4.877 millions
Birner Dental Management Services Inc -5.03 %$ -5.032 millions
Msa Safety Incorporated -5.19 %$ -5.187 millions
Spark Therapeutics, Inc. -5.20 %$ -5.204 millions
Biolase, Inc -5.21 %$ -5.208 millions
Rockwell Medical, Inc. -5.26 %$ -5.256 millions
Lifevantage Corp -5.86 %$ -5.862 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
ZARTEX's Profile
Stock Price
ZARTEX's Financials
ZARTEX's Expectations
Business Description
Fundamentals
Charts & Quotes
ZARTEX's News
Suppliers
ZARTEX's Competitors
Customers & Markets
Economic Indicators
ZARTEX's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com